EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug repurposing to combat multidrug-resistant hookworm

Elise L McKean, Catherine A Jackson, Abigail Dowd, John M Hawdon, Damien M O'Halloran iD

Biology Open · 2026

DOI: 10.1242/bio.062380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology Open, 2026. Verfasst von Elise L McKean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, The George Washington University, Washington, DC 20052, USA. Hauptthemen laut MEDLINE: Drug Repositioning, Anthelmintics, Ancylostoma, Drug Resistance, Multiple. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, George Washington University, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthelmintic resistance (AR) poses an escalating threat to global soil-transmitted helminth control efforts, particularly in the context of mass drug administration (MDA) programs that rely heavily on benzimidazole drugs. To address the urgent need for novel therapeutics, a machine learning (ML) guided drug repurposing pipeline was developed to identify compounds effective against a multi-anthelmintic drug-resistant (MADR) isolate of Ancylostoma caninum. The computational strategy employed in this work involved training classifiers on curated datasets of anthelmintic actives and decoys, followed by screening all approved drugs from the online database, DrugBank. Selected compounds were tested using a tiered assay system comprising egg hatch assays (EHA), larval development assays (LDA), and adult survival assays. Among these, flutamide, a nonsteroidal antiandrogen approved for prostate cancer, demonstrated potent, egg- and larval-stage-specific activity against MADR hookworm. Flutamide exhibited a concentration-dependent inhibition of egg hatching and arrested larval development in MADR hookworm. These findings underscore the translational value of drug repurposing to accelerate therapeutic discovery against MADR helminths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAnthelminticsAncylostomaDrug Resistance, MultipleAncylostomatoideaHookworm InfectionsAnimalsMachine LearningHumans

Stichwörter der Autor:innen

Ancylostoma caninumAnthelmintic resistanceDrug repurposingHookwormMachine learning

Substanzen

Anthelmintics

Autor:innen und Institutionen

  • Department of Biological Sciences, The George Washington University, Washington, DC 20052, USA.
  • Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC 20052, USA.

ORCID-Profile: Damien M O'Halloran

Förderung

  • NIAID NIH HHS
  • George Washington University
  • NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

McKean, E. L., Jackson, C. A., Dowd, A., Hawdon, J. M., & O'Halloran, D. M. (2026). Drug repurposing to combat multidrug-resistant hookworm. Biology Open. https://doi.org/10.1242/bio.062380

Vancouver

McKean EL, Jackson CA, Dowd A, Hawdon JM, O'Halloran DM. Drug repurposing to combat multidrug-resistant hookworm. Biology Open. 2026. doi:10.1242/bio.062380

BibTeX
@article{McKean2026,
  author = {McKean, Elise L and Jackson, Catherine A and Dowd, Abigail and Hawdon, John M and O'Halloran, Damien M},
  title = {Drug repurposing to combat multidrug-resistant hookworm},
  journal = {Biology Open},
  year = {2026},
  doi = {10.1242/bio.062380}
}
Kostenlos starten →